Datametrex Strengthens Board With Appointment of Benj Gallander


TORONTO, June 25, 2020 (GLOBE NEWSWIRE) -- Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Mr. Benj Gallander as a new independent member of the Board of Directors.

“Benj has worked with start-ups and corporations of various sizes. He has built his company over 25 years and understands the buy side in great detail, as well as corporate turnarounds. His background in investments greatly strengthens our company,” stated Marshall Gunter, CEO of Datametrex. “Benj is highly accomplished and connected within the investor community.”

To support Datametrex’s growth, Mr. Gallander brings over 40 years of experience in the markets, with ample skills in integrating business and strategic investors and his know-how bringing innovation to companies.  Over time, he has refined his approach to investing and has achieved one of the best track records in the investment industry. Mr. Gallander is co-editor of Contra the Heard investment letter and over the past ten years the portfolio he manages achieved an annualized return of 18.4%. Benj co-writes "The Contra Guys" column for The Globe and Mail and is an author of three best-selling books, writes for several magazines, and has been a regular on BNN Bloomberg since virtually the beginning.

“Datametrex is poised to leverage their technology acumen and proven client solution capability. Datametrex’s recent initiative in COVID-19 testing kits has enabled the company to transform and breakthrough into society as a trusted and essential partner. I am looking forward to working with Marshall and the team at Datametrex,” said Benj. 

The company has issued Mr. Gallander 1,000,000 options at a strike price of C$0.10, being the closing price of the common shares of the Company on June 24, 2020.

As part of Board changes, Charles Schade is stepping down from the Board and will be joining the Company’s Advisory Board. Charles joined the company from the start and was the longest serving Board member.  The Company would like to thank Charles for his active contribution to the Board and looks forward to continuing to work with him as a member of the Advisory Board to the Company.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: mgunter@datametrex.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.



Mot-clé